UPEXI, INC.
For the period ended Jun 30, 2026. Filed Sep 17, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2026 · Filed Sep 17, 2026
UPXI$0.62-6.2%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Statements of Cash Flows
CONSOLIDATED STATEMENTS OF CASH FLOWS
| Year Ended June 30, | ||
|---|---|---|
| 2026 | 2025 | |
| Cash flows from operating activities | ||
| Net loss | $(246,064,698) | $(13,684,209) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Depreciation and amortization | 456,249 | 757,758 |
| Unrealized loss (gain) on digital assets | 195,059,336 | (101,332) |
| Realized loss on sale of digital assets | 6,773,418 | - |
| Digital asset revenue | (17,429,206) | (985,009) |
| Digital asset revenue conversion to USD | 13,192,785 | - |
| Realized loss on digital asset revenue conversion to USD | 4,931,791 | - |
| Amortization of loan costs | 3,655,535 | 30,462 |
| Loss on disposal of property and equipment | 237,727 | 10,743 |
| Gain on extinguishment of debt | (10,288,342) | - |
| Inventory write-off | - | 748,874 |
| Bad debt reserve for Amazon receivable | - | 933,950 |
| Reduction of acquisition payable | - | (152,500) |
| Lease impairment (gain on settlement) | - | (269,994) |
| Impairment on assets from manufacturing shut down | 1,422,289 | - |
| Impairment on acquired intangible assets | 750,000 | - |
| Issuance of stock for services | - | 250,000 |
| Stock-based compensation | 21,895,814 | 2,106,862 |
| Changes in assets and liabilities | ||
| Accounts receivable | 60,271 | (484,580) |
| Inventory | 886,909 | (470,188) |
| Prepaid expenses and other assets | (411,616) | 222,005 |
| Operating lease payable | (26,667) | 20,965 |
| Accounts payable and accrued liabilities | 3,950,834 | 2,865,251 |
| Deferred revenue | (8,636) | (222,100) |
| Net cash used in operating activities | (20,956,207) | (8,423,042) |
| Cash flows from investing activities | ||
| Proceeds from the sale of building | - | 4,005,516 |
| Proceeds from the sale of E-core | - | 2,000,000 |
| Proceeds from the sale of MW Products assets | 175,000 | - |
| Proceeds from the sale of VitaMedica, Inc. | 2,000,000 | - |
| Acquisition of digital assets | (40,035,365) | (104,910,839) |
| Proceeds from the sale of digital assets | 8,030,606 | - |
| Acquisition of royalty interest | (750,000) | - |
| Acquisition of property and equipment | (44,002) | (387,760) |
| Net cash used in investing activities | (30,623,761) | (99,293,083) |
| Cash flows from financing activities | ||
| Proceeds from issuance of common stock | 75,158,289 | 92,556,053 |
| Issuance of preferred stock series A | - | 325,000 |
| Proceeds from exercise of warrants | 107,889 | 250,000 |
| Repurchases of common stock | (2,773,959) | - |
| Proceeds from short-term treasury debt | 5,000,000 | - |
| Repayment of short-term treasury debt | (10,400,000) | - |
| Proceeds from issuance of convertible notes | - | 350,000 |
| Repayment of promissory notes | (560,000) | - |
| Proceeds from related party advance | - | 75,000 |
| Repayment of related party advance | - | (175,000) |
| Payments of equity issuance costs | (4,519,873) | - |
| Payments of debt issuance costs | (7,628,942) | - |
| Payment on acquisition notes payable | - | (66,655) |
| Payment on convertible note | - | (150,000) |
| Proceeds from issuance of short-term debt | - | 20,000,000 |
| Repayment of related party note payable | - | (500,000) |
| Repayment on note payable on building | - | (2,634,538) |
| Net cash provided by financing activities | 54,383,404 | 110,029,860 |
| Net increase in cash | 2,803,436 | 2,313,735 |
| Cash, beginning of period | 2,975,150 | 661,415 |
| Cash, end of period | $5,778,586 | $2,975,150 |
| Supplemental Cash Flow Disclosures | ||
| Interest paid | $8,372,056 | $805,880 |
| Income tax paid | 11,313 | - |
| Non-cash Investing and Financing Activities | ||
| Issuance of common stock for the repayment of convertible notes payable | $12,285,122 | $1,750,000 |
| Issuance of convertible debt for digital assets acquired | 187,131,144 | - |
| Issuance of short-term debt for digital assets acquired | 42,695,723 | - |
Upexi, Inc.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.